Literature DB >> 15246372

Fully automated synthesis system of 3'-deoxy-3'-[18F]fluorothymidine.

Seung Jun Oh1, Christoph Mosdzianowski, Dae Yoon Chi, Jung Young Kim, Se Hun Kang, Jin Sook Ryu, Jeong Seok Yeo, Dae Hyuk Moon.   

Abstract

We developed a new fully automated method for the synthesis of 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT), by modifying a commercial FDG synthesizer and its disposable fluid pathway. Optimal labeling condition was that 40 mg of precursor in acetonitrile (2 mL) was heated at 150 degrees C for 100 sec, followed by heating at 85 degrees C for 450 sec and hydrolysis with 1 N HCl at 105 degrees C for 300 sec. Using 3.7 GBq of [18F]F- as starting activity, [18F]FLT was obtained with a yield of 50.5 +/- 5.2% (n = 28, decay corrected) within 60.0 +/- 5.4 min including HPLC purification. With 37.0 GBq, we obtained 48.7 +/- 5.6% (n = 10). The [18F]FLT showed the good stability for 6 h. This new automated synthesis procedure combines high and reproducible yields with the benefits of a disposable cassette system. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246372     DOI: 10.1016/j.nucmedbio.2004.01.008

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  18 in total

1.  [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.

Authors:  Seung Jin Choi; Jae Seung Kim; Jeong Hoon Kim; Seung Jun Oh; Jeong Gyo Lee; Chang Jin Kim; Young Shin Ra; Jeong Seok Yeo; Jin Sook Ryu; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-15       Impact factor: 9.236

2.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

3.  A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.

Authors:  Masatoyo Nakajo; Yoriko Kajiya; Atsushi Tani; Megumi Jinguji; Masayuki Nakajo; Masaki Kitazono; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-03       Impact factor: 9.236

4.  Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Yuko Goto; Megumi Jinguji; Sadao Tanaka; Yoshihiko Fukukura; Atsushi Tani; Michiyo Higashi
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

Review 5.  Non-FDG PET/CT in Diagnostic Oncology: a pictorial review.

Authors:  Francesco Giammarile; Paolo Castellucci; Rudi Dierckx; Enrique Estrada Lobato; Mohsen Farsad; Roland Hustinx; Amirreza Jalilian; Olivier Pellet; Susana Rossi; Diana Paez
Journal:  Eur J Hybrid Imaging       Date:  2019-11-29

6.  Production of diverse PET probes with limited resources: 24 18F-labeled compounds prepared with a single radiosynthesizer.

Authors:  Jeffrey Collins; Christopher M Waldmann; Christopher Drake; Roger Slavik; Noel S Ha; Maxim Sergeev; Mark Lazari; Bin Shen; Frederick T Chin; Melissa Moore; Saman Sadeghi; Michael E Phelps; Jennifer M Murphy; R Michael van Dam
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

7.  [(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study.

Authors:  Eliot T McKinley; Jennifer M Watchmaker; A Bapsi Chakravarthy; Jeffrey A Meyerhardt; Jeffrey A Engelman; Ronald C Walker; M Kay Washington; Robert J Coffey; H Charles Manning
Journal:  Ann Nucl Med       Date:  2015-04-22       Impact factor: 2.668

8.  FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Yoshihiko Fukukura; Yoriko Kajiya; Atushi Tani; Masayuki Nakajo; Yoshiaki Nakabeppu; Hiroshi Arimura; Yoshihiko Nishio; Fumihiko Nakamura; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2015-04-30       Impact factor: 5.315

9.  Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.

Authors:  Muhammad Rashed Javed; Supin Chen; Hee-Kwon Kim; Liu Wei; Johannes Czernin; Chang-Jin C J Kim; R Michael van Dam; Pei Yuin Keng
Journal:  J Nucl Med       Date:  2013-12-23       Impact factor: 10.057

10.  3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.

Authors:  Eliot T McKinley; R Adam Smith; Ping Zhao; Allie Fu; Samir A Saleh; Md Imam Uddin; M Kay Washington; Robert J Coffey; H Charles Manning
Journal:  J Nucl Med       Date:  2013-01-22       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.